Core Insights - Greenway Greenhouse Cannabis Corporation has entered into a supply agreement with 4C LABS, a UK-based medical cannabis company, to provide high-quality dried flower products [1][2] - The partnership aims to leverage the reputation of Canadian cannabis as a gold standard for quality and safety, targeting the growing international medical cannabis market [3] Company Overview - Greenway is a federally licensed cultivator based in Kingsville, Ontario, specializing in high-quality greenhouse cannabis for the Canadian market [7] - The company aims to expand its reach by collaborating with international partners, which is expected to yield better margins compared to the domestic market [3] Partnership Details - The agreement with 4C LABS will enable Greenway to supply its products to a leading importer and distributor of cannabis-based pharmaceuticals in the UK [2] - 4C LABS is focused on providing affordable, world-class medical cannabis products to UK pharmacies, clinics, and patients [6] Share Issuance - Greenway has issued 337,507 common shares to Abingdon Capital Corporation at prices between $0.20 and $0.29 per share as part of a corporate finance advisory service agreement [4]